CURE vs. PDBC
CURE (Direxion Daily Healthcare Bull 3x Shares) and PDBC (Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF) are both exchange-traded funds - CURE is a Leveraged Equities fund tracking the Health Care Select Sector Index (300%), while PDBC is a Commodities fund actively managed by Invesco. CURE is passively managed, while PDBC is actively managed. Over the past 10 years, CURE returned 13.78%/yr vs 8.14%/yr for PDBC. At a 0.10 correlation, their price movements are largely independent. CURE charges 1.08%/yr vs 0.58%/yr for PDBC.
Performance
CURE vs. PDBC - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CURE achieves a 5.86% return, which is significantly lower than PDBC's 27.55% return. Over the past 10 years, CURE has outperformed PDBC with an annualized return of 13.78%, while PDBC has yielded a comparatively lower 8.14% annualized return.
CURE
- 1D
- 0.90%
- 1M
- 15.02%
- 6M
- 1.24%
- YTD
- 5.86%
- 1Y
- 50.47%
- 3Y*
- 7.93%
- 5Y*
- 2.19%
- 10Y*
- 13.78%
PDBC
- 1D
- 2.80%
- 1M
- -0.94%
- 6M
- 22.82%
- YTD
- 27.55%
- 1Y
- 30.72%
- 3Y*
- 10.42%
- 5Y*
- 10.81%
- 10Y*
- 8.14%
CURE vs. PDBC - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
CURE Direxion Daily Healthcare Bull 3x Shares | 5.86% | 22.55% | -8.47% | -9.40% | -20.51% | 88.30% | 5.02% | 55.66% | 2.82% | 69.32% |
PDBC Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF | 27.55% | 5.96% | 2.09% | -6.25% | 19.23% | 41.72% | -7.84% | 11.44% | -12.78% | 5.06% |
Correlation
The correlation between CURE and PDBC is -0.23, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.23 |
Correlation (3Y) Calculated over the trailing 3-year period | -0.12 |
Correlation (5Y) Calculated over the trailing 5-year period | -0.00 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.09 |
Correlation (All Time) Calculated using the full available price history since Nov 7, 2014 | 0.10 |
The correlation between CURE and PDBC shifts across timeframes, from -0.23 (1 year) to 0.10 (all time), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CURE vs. PDBC — Risk / Return Rank
CURE
PDBC
CURE vs. PDBC - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Direxion Daily Healthcare Bull 3x Shares (CURE) and Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF (PDBC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CURE | PDBC | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.54 | ||
| Sortino ratioReturn per unit of downside risk | -0.43 | ||
| Omega ratioGain probability vs. loss probability | 1.20 | 1.28 | -0.08 |
| Calmar ratioReturn relative to maximum drawdown | 1.63 | 1.86 | -0.23 |
| Martin ratioReturn relative to average drawdown | 3.63 | 6.57 | -2.94 |
Loading charts...
Drawdowns
CURE vs. PDBC - Drawdown Comparison
The maximum CURE drawdown since its inception was -69.19%, which is greater than PDBC's maximum drawdown of -49.52%. Use the drawdown chart below to compare losses from any high point for CURE and PDBC.
Loading charts...
Drawdown Indicators
| CURE | PDBC | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -69.19% | -49.52% | -19.67% |
Max Drawdown (1Y)Largest decline over 1 year | -31.10% | -16.55% | -14.55% |
Max Drawdown (3Y)Largest decline over 3 years | -51.93% | -16.55% | -35.38% |
Max Drawdown (5Y)Largest decline over 5 years | -52.23% | -27.63% | -24.60% |
Max Drawdown (10Y)Largest decline over 10 years | -69.19% | -40.73% | -28.46% |
Current DrawdownCurrent decline from peak | -15.97% | -10.63% | -5.34% |
Average DrawdownAverage peak-to-trough decline | -18.17% | -23.11% | +4.94% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 13.93% | 4.69% | +9.24% |
Volatility
CURE vs. PDBC - Volatility Comparison
Direxion Daily Healthcare Bull 3x Shares (CURE) has a higher volatility of 16.89% compared to Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF (PDBC) at 6.25%. This indicates that CURE's price experiences larger fluctuations and is considered to be riskier than PDBC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CURE | PDBC | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 16.89% | 6.25% | +10.64% |
Volatility (6M)Calculated over the trailing 6-month period | 33.63% | 16.77% | +16.86% |
Volatility (1Y)Calculated over the trailing 1-year period | 46.46% | 18.90% | +27.56% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 44.39% | 19.24% | +25.15% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 49.69% | 17.76% | +31.93% |
CURE vs. PDBC - Expense Ratio Comparison
CURE has a 1.08% expense ratio, which is higher than PDBC's 0.58% expense ratio.
Dividends
CURE vs. PDBC - Dividend Comparison
CURE's dividend yield for the trailing twelve months is around 1.07%, less than PDBC's 3.01% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
CURE Direxion Daily Healthcare Bull 3x Shares | 1.07% | 1.12% | 1.17% | 2.02% | 0.38% | 0.02% | 0.17% | 0.40% | 0.70% | 0.18% | 0.00% |
PDBC Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF | 3.01% | 3.84% | 4.42% | 4.21% | 13.05% | 50.83% | 0.01% | 1.40% | 1.00% | 3.83% | 6.51% |
Frequently Asked Questions
CURE and PDBC have a correlation of -0.23, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CURE has higher volatility (16.89%) compared to PDBC (6.25%). In terms of maximum drawdown, CURE dropped -69.19% vs PDBC's -49.52%.
On 10-year performance, CURE leads with 13.78% vs 8.14% for PDBC. On fees, PDBC is cheaper at 0.58% per year. On volatility, PDBC has been the lower-risk option at 6.25%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, CURE has performed better with a 13.78% return vs 8.14%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
PDBC is cheaper with a 0.58% expense ratio, compared with 1.08% for CURE.
PDBC has the higher dividend yield at 3.01%, compared with 1.07% for CURE.
CURE is categorized as Leveraged Equities, while PDBC is Commodities. They also come from different issuers: Direxion and Invesco. Their fees differ too: 1.08% for CURE and 0.58% for PDBC.
PDBC currently has the higher Sharpe Ratio (1.64 vs 1.09), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CURE and PDBC
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer